A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
Antag Therapeutics · Adults With Overweight/Obesity and Type 2 Diabetes
Phase 2
Recruiting
150
2026-07